🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
This phase II trial studies how well de-escalating the drugs dabrafenib and...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-11-07
Trial ID
NCT07110246
This phase II MATCH treatment trial identifies the effects of trametinib in...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-02-25
Trial ID
NCT04439357
Treatments Being Tested
This phase I/II trial investigates the best dose, possible benefits and/or ...
Status
Active Not Recruiting
Location
UM Sylvester Comprehensive Cancer Center at Aventura
Start Date
2021-08-19
Trial ID
NCT04557956
This phase I/II trial studies the side effects and the best dose of uproser...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2013-10-08
Trial ID
NCT01902173
This phase II/III trial studies how well trametinib works and compares it t...
Status
Completed
Location
Tennessee Valley Gynecologic Oncology
Start Date
2014-04-11
Trial ID
NCT02101788
This phase II trial investigates how well adding hydroxychloroquine to the ...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-06-01
Trial ID
NCT04527549
Treatments Being Tested
This phase II trial studies the side effects and how well dabrafenib and tr...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2019-01-04
Trial ID
NCT03794297
This phase II MATCH treatment trial identifies the effects of trametinib in...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2015-08-12
Trial ID
NCT04439279
Treatments Being Tested
This phase I/II trial is designed to study the side effects, best dose and ...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-01-17
Trial ID
NCT04201457
Treatments Being Tested